Novo Nordisk A/S (NYSE:NVO)

48.10
Delayed Data
As of 4:02pm ET
 -0.17 / -0.35%
Today’s Change
41.03
Today|||52-Week Range
58.37
-10.38%
Year-to-Date

Today’s Trading

Previous close48.27
Today’s open47.96
Day’s range47.79 - 48.24
Volume1,128,371
Average volume (3 months)1,532,919
Market cap$92.8B
Data as of 4:02pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+6.29%
Earnings growth (this year)+3.34%
Earnings growth (next 5 years)+6.56%
Revenue growth (last year)+3.25%
P/E ratio19.4
Price/Sales7.77
Price/Book15.20

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.67+1.08%
LLYEli Lilly and Co+0.03+0.04%
BMYBristol-Myers Squibb+0.19+0.36%
GSKGlaxoSmithKline-0.15-0.37%
Data as of 4:02pm ET, 05/24/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$0.66
Annual revenue (last year)$17.1B
Annual profit (last year)$5.8B
Net profit margin34.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts